Aspire Biopharma Holdings, Inc. to Launch its BUZZ BOMB Pre-Workout Supplement at FitCon and FitExpo, Two of the Largest Fitness Conventions in the World
-
US consumer confidence tumbles in December
-
Norwegian biathlete Sivert Guttorm Bakken found dead in hotel
-
UK comedian Russell Brand faces two new rape, assault charges: police
-
Venezuela seeks to jail backers of US oil blockade
-
Norwegian biathlete Sivert Guttorm Bakken found dead
-
Wall Street stocks edge higher
-
Vietnam Communist Party endorses To Lam to stay in top job
-
US economic growth surges in 3rd quarter, highest rate in two years
-
Frank defends Van de Ven after Slot slams 'reckless' foul on Isak
-
Russian paramilitaries in CAR say take election threat 'extremely seriously'
-
Trump in the Epstein files: five takeaways from latest release
-
UK govt to relax farmers inheritance tax after protests
-
Pakistani firm wins auction for state airline PIA
-
Stocks slip on strong US growth data
-
DR Congo beat Benin to kick off Cup of Nations bid
-
New Epstein files dump contains multiple Trump references
-
Russian strike could collapse Chernobyl shelter: plant director
-
Springbok captain Kolisi to rejoin Stormers
-
Italy fines Ryanair $300 mn for abuse of dominant position
-
Mahrez eyes strong AFCON showing from Algeria
-
Killer in Croatia school attack gets maximum 50-year sentence
-
Thousands of new Epstein-linked documents released by US Justice Dept
-
Stocks steady as rate cut hopes bring Christmas cheer
-
Bangladesh summons Indian envoy as protest erupts in New Delhi
-
Liverpool's Isak faces two months out after 'reckless' tackle: Slot
-
For director Josh Safdie, 'Marty Supreme' and Timothee Chalamet are one and the same
-
Kyiv's wartime Christmas showcases city's 'split' reality
-
Locals sound alarm as Bijagos Islands slowly swallowed by sea
-
Cambodia asks Thailand to move border talks to Malaysia
-
In Bulgaria, villagers fret about euro introduction
-
Key to probe England's 'stag-do' drinking on Ashes beach break
-
Delayed US data expected to show solid growth in 3rd quarter
-
Thunder bounce back to down Grizzlies, Nuggets sink Jazz
-
Amazon says blocked 1,800 North Koreans from applying for jobs
-
Trump says US needs Greenland 'for national security'
-
Purdy first 49er since Montana to throw five TDs as Colts beaten
-
North Korea's Kim tours hot tubs, BBQ joints at lavish new mountain resort
-
Asian markets rally again as rate cut hopes bring Christmas cheer
-
Australian state poised to approve sweeping new gun laws, protest ban
-
Trapped under Israeli bombardment, Gazans fear the 'new border'
-
Families want answers a year after South Korea's deadliest plane crash
-
Myanmar's long march of military rule
-
Disputed Myanmar election wins China's vote of confidence
-
Myanmar junta stages election after five years of civil war
-
Ozempic Meals? Restaurants shrink portions to match bite-sized hunger
-
'Help me, I'm dying': inside Ecuador's TB-ridden gang-plagued prisons
-
Australia's Cummins, Lyon out of fourth Ashes Test
-
US singer Barry Manilow reveals lung cancer diagnosis
-
'Call of Duty' co-creator Vince Zampella killed in car crash
-
Investor Tools Highlighted by BNK Invest
NYSE - LSE
| SCS | 0.12% | 16.14 | $ | |
| CMSC | 0.01% | 23.1399 | $ | |
| BCC | -1.28% | 73.29 | $ | |
| AZN | 0.47% | 91.985 | $ | |
| BCE | -0.11% | 22.705 | $ | |
| RIO | 1.15% | 81.03 | $ | |
| NGG | 1.09% | 77.255 | $ | |
| BTI | 0.36% | 56.975 | $ | |
| CMSD | -0.78% | 23.02 | $ | |
| GSK | 0.3% | 48.735 | $ | |
| JRI | 0.37% | 13.42 | $ | |
| BP | 1.16% | 34.541 | $ | |
| RBGPF | 0% | 80.22 | $ | |
| RELX | -0.09% | 40.945 | $ | |
| VOD | 1.23% | 13.04 | $ | |
| RYCEF | 0.19% | 15.53 | $ |
Aspire Biopharma Holdings, Inc. to Launch its BUZZ BOMB Pre-Workout Supplement at FitCon and FitExpo, Two of the Largest Fitness Conventions in the World
Sublingual nano technology delivers 50mg of caffeine rapidly to the body, bringing its unique benefits to the pre-workout market
ESTERO, FL / ACCESS Newswire / July 22, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), developer of a multi-faceted patent-pending supplement delivery technology, today announced it plans to launch its newsublingual pre-workout supplement, BUZZ BOMB™, at FitCon and FitExpo, two of the largest fitness conventions held annually in Salt Lake City, Utah (August 1-2) and Anaheim, CA, (August 2-3), respectively.
Featuring 50mg of caffeine and designed to support sustained energy and mental focus, BUZZ BOMB™ is bringing its unique delivery technology benefits to the multi-billion-dollar pre-workout market to help athletes and fitness enthusiasts maximize their performance potential. Buzz BOMB™, offered in four flavors, provides nearly instant energy, in easy-to-use small sublingual packets, which can be taken right before and during work out as needed. Unlike pre-workout products that are mixed with water and taken well before a workout, BUZZ BOMB™ is sprinkled under the tongue for immediate effect.
FitCon: Mountain America ExpoCenter, Salt Lake City, UT on August 1-2, 2025, Located in Sponsor Alley
FitCon is an event that brings together fitness enthusiasts, professionals, brands, and influencers in the health and wellness industry with approximately 20,000 attendees and hundreds of exhibitors. BUZZ BOMB™ is one of seven "Gold Sponsors" at FitCon, which provides benefits including samples provided to every attendee, a large booth located along "Sponsor Alley" where all attendees pass through, as well as FitCon website marketing, advertising and communications to attendees, and a liberal exhibiting of Buzz Bomb's distinctive trademark throughout the exhibition.
To learn more about FitCon, please visit https://fitcon.com/
The FitExpo: Anaheim Convention Center, Anaheim, CA, August 2-3, 2025, Booth #401
FitExpo brings together a diverse range of fitness brands, competitions, and demonstrations to inspire and guide individuals on their fitness journey and is one of the largest fitness conventions in the world with over 33,000 people expected to attend. As a convention sponsor, BUZZ BOMB™ will be provided numerous benefits and support, including:
Booth # 401 is the first one nearest the entry doors to the convention
FitExpo will publish a pre-convention media blast about BUZZ BOMB™ to over 1.8 million social media accounts including all attendees
BUZZ BOMB™ will be mentioned on all signage throughout the convention, including in the lobby where patrons enter, as well as on the convention's website, newsletter, and social media postings
BUZZ BOMB™ products will be in the gift bag given to every entrant (a sample pack of 4 different flavors)
BUZZ BOMB is planned to be personally introduced to each influencer at the show
Learn more about FitExpo at https://thefitexpo.com/cities/anaheim/
Company representatives (mostly professional trainers) will be running "Feel the Buzz" contests at both conventions with 250 BUZZ BOMB™ t-shirts offered as prizes to contestants. The Company also plans to sell product at the conventions and generate "BUZZ".
"The launch of BUZZ BOMB™ at two of the major fitness conventions represent the ideal venues to introduce our disruptive pre-workout formula designed to boost endurance, energy metabolism, and overall performance, ensuring that athletes and fitness enthusiasts can perform at their best, both in and out of the gym," said Michael Howe, Chief Executive Officer of Aspire. "We are also very excited about the positive initial consumer feedback we received recently from our sampling of BUZZ BOMB™ to not only fitness trainers and gym owners, but to active and fitness-minded consumers, expanding the addressable market opportunity within the multi-billion-dollar health and wellness categories."
BUZZ BOMB™ Pre-workout Benefits:
• Speed - works nearly immediate vs. 20-30 minutes
• Convenience - easy to use single-use packets vs. mixing and measuring for beverages
• Energy management - use as needed to precisely manage caffeine intake
• Single Safe Active Ingredient - well-known benefits and use of caffeine
• Low manufacturing & packaging costs - competitive pricing with high margin potential
About the Aspire Targeted Oral Delivery Platform
Aspire's technology delivers fast-acting supplement formulations which have been developed by using our patent-pending methodology, and "trade secret" process. The technology's new mechanism of action allows for rapid sublingual absorption. The benefits of "rapid absorption" are to provide rapid impact in more precise quantities.
About Aspire Biopharma, Inc.
Headquartered in Estero, Fl., Aspire Biopharma has developed a disruptive technology that can deliver supplements and drugs rapidly and precisely. For more information, please visit www.aspirebiolabs.com.
Safe Harbor Statement
Certain statements made in this communication are "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may generally be identified by the use of words such as "estimate," "projects," "expects," "anticipates," "forecasts," "plans," "intends," "believes," "seeks," "may," "will," "would," "should," "future," "propose," "potential," "target," "goal," "objective," "outlook" and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements include, but are not limited to, statements regarding the financial position, business strategy and the plans and objectives of management for future operations. These statements are based on various assumptions, whether or not identified in this communication, and on the current expectations of Aspire's management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as and must not be relied on by any investor as a guarantee, an assurance, a prediction or a definitive statement of fact or probability. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the control of the parties, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.
Aspire Biopharma Holdings, Inc.
Contact
PCG Advisory
Kevin McGrath
+1-646-418-7002
[email protected]
SOURCE: Aspire Biopharma Holdings, Inc.
View the original press release on ACCESS Newswire
L.Miller--AMWN